QA: ImmunoGen Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000855654_2023_ImmunoGen_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000855654, ImmunoGen Inc.

  xvar xval
0 AssetsCurrent 304,121,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,377,000
3 remainder_Assets 40,438,000
4 LiabilitiesCurrent 121,858,000
5 LiabilitiesNoncurrent 47,803,000
6 remainder_Liabilities 23,449,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 116,129,000
9 ResearchAndDevelopmentExpense 213,370,000
10 remainder_Expenses 5,559,000
11 remainder_Revenues 108,782,000
12 remainder_NetIncome 3,347,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 348,936,000
1 Liabilities 193,110,000
2 Expenses 335,058,000
3 Revenues 108,782,000
4 StockholdersEquity 155,826,000
5 NetIncome -222,929,000
6 ComprehensiveNetIncome -222,929,000
7 BaseVar 494,616,500
8 EconomicCapitalRatio 0.166

Edgar->Model Mapping

Feature Distribution

Change over Time